ArticleScientific reports2025
Optimizing breast cancer classification based on cat swarm-enhanced ensemble neural network approach for improved diagnosis and treatment decisions.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A multi-scale hybrid ResNet-transformer with distance-aware learning for interpretable BI-RADS mammographic classification.Scientific reports · 2026Article
- SMBO: a Sinusoidal Modulation Bi-population Optimizer for brain cancer MRI image clustering.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer remains a formidable global health challenge, emphasizing the critical importance of accurate and early diagnosis for improved patient outcomes. In recent years, machine learning, particularly deep learning, has shown substantial promise in assisting medical practitioners with breast cancer classification tasks. However, achieving consistently high accuracy and robustness in the classification process remains a significant challenge due to the inherent complexity and heterogeneity of breast cancer data. This study introduces an innovative approach to optimize breast cancer classification using the CS-EENN Model by harnessing the combined power of Cat Swarm Optimization (CSO) and an Enhanced Ensemble Neural Network approach. The ensemble approach capitalizes on the strengths of EfficientNetB0, ResNet50, and DenseNet121 architectures, known for their superior performance in computer vision tasks, to achieve a multifaceted understanding of breast cancer data. CSO employed to optimize the architecture and hyperparameters of these neural networks, enhancing their performance by facilitating convergence and preventing overfitting. Experimental evaluations conducted on the publicly available 'Breast Histopathology Images' dataset from Kaggle demonstrate the effectiveness of the proposed approach. The CS-EENN model achieved an impressive accuracy of 98.19%, significantly outperforming conventional methods. These advancements expected to have a direct and favourable impact on the accuracy of breast cancer detection and subsequent treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.